Semaglutide: A Novel Oral Glucagon-Like Peptide (GLP-1) Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus.
Diabetes mellitus (DM) is a complex and chronic condition that requires continuous medical care. Uncontrolled hyperglycemia can lead to serious microvascular and macrovascular complications,...